- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.10. | Ardent Health, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 21.10. | Ardent Health ernennt Gaurav Khanna zum Chief Digital and Information Officer | 1 | Investing.com Deutsch | ||
| 21.10. | Ardent Health names Gaurav Khanna as chief digital officer | 2 | Investing.com | ||
| 22.09. | BMO initiates Ardent Health stock with Market Perform rating | 2 | Investing.com | ||
| 22.09. | BMO Capital startet Coverage für Ardent Health mit "Market Perform" | 3 | Investing.com Deutsch | ||
| 04.09. | Ardent Health, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| ARDENT HEALTH Aktie jetzt für 0€ handeln | |||||
| 10.08. | RBC Capital raises Ardent Health stock price target on EBITDA beat | 1 | Investing.com | ||
| 06.08. | Guggenheim hebt Kursziel für Ardent Health nach übertroffenem EBITDA an | 1 | Investing.com Deutsch | ||
| 06.08. | Guggenheim raises Ardent Health stock price target on EBITDA beat | 1 | Investing.com | ||
| 05.08. | Ardent Health offsets Q2 volume stumble by tightening costs, renegotiating contracts | 1 | FierceHealthcare | ||
| 05.08. | Ardent Health Aktie steigt um 8 % trotz verfehlter Gewinnprognose für Q2 2026 | 1 | Investing.com Deutsch | ||
| 04.08. | Ardent Health, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 30.06. | Ardent Health, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 10.06. | Ardent Health's surprise CEO change reflected need for margin focus amid headwinds, CFO says | 2 | FierceHealthcare | ||
| 07.06. | Chutes & Ladders-Ardent Health appoints new CEO; KFF Founding President, CEO to retire | 5 | FierceHealthcare | ||
| 03.06. | Ardent Health Names Dave Caspers President, CEO; Backs FY View After Q2 Volume Softness; Stock Down | 13 | RTTNews | ||
| 02.06. | Ardent Health names insider Dave Caspers CEO | 1 | Seeking Alpha | ||
| 02.06. | Führungswechsel bei Ardent Health: Dave Caspers wird neuer CEO | 1 | Investing.com Deutsch | ||
| 02.06. | Ardent Health names Dave Caspers as new CEO | 1 | Investing.com | ||
| 26.05. | Ardent Health, Inc. - 8-K, Current Report | 1 | SEC Filings |
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 7,706 | -0,13 % | Piper Sandler raises Teladoc stock price target on BetterHelp growth | ||
| SERNOVA BIOTHERAPEUTICS | 0,068 | +21,15 % | Sernova Biotherapeutics, Inc.: Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical Trial | TORONTO and GERMANTOWN, Md., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO) and Seraxis Holdings, Inc. ("Seraxis") today announced... ► Artikel lesen | |
| CERENOME | 1,420 | 0,00 % | Cerenome completes enrollment in glioblastoma drug trial | ||
| ATOSSA THERAPEUTICS | 2,040 | +0,99 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -5- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameUS75973T2006 RENALYTIX... ► Artikel lesen | |
| TANDEM DIABETES | 17,000 | +1,80 % | Tandem Diabetes Care, Inc.: Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets | Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world's smallest, durable automated insulin delivery... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,353 | -0,03 % | Co-Diagnostics' Joint Venture CoSara Diagnostics Completes Clinical Study and Regulatory Submission for Point-of-Care Tuberculosis Test, Sets Stage for Commercial Launch in India | CDSCO Clearance and Commercial Launch in India Anticipated Before Year-End 2026Study Demonstrated 97.3% Sensitivity and 96.0% SpecificityConsistent Performance Across Three Test BatchesIntegrated Mobile... ► Artikel lesen | |
| QUIDELORTHO | 11,630 | -7,18 % | Quidel Q3 2026 Earnings Preview | ||
| VERU | 2,160 | 0,00 % | Oppenheimer reiterates Veru stock rating ahead of obesity trial data | ||
| LIFEWARD | 6,040 | -1,31 % | Lifeward Ltd. - 8-K, Current Report | ||
| CLOVER HEALTH INVESTMENTS | 3,840 | -0,52 % | Clover Health im Aufwind: Needham startet Coverage mit "Buy" und Kursziel von 6 Dollar | ||
| SENSEONICS | 8,000 | -0,62 % | Beta Bionics, Inc.: Beta Bionics Announces Agreement Integrate the iLet Bionic Pancreas and mint with Senseonics' Eversense 365 | IRVINE, Calif., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced a partnership... ► Artikel lesen | |
| NANO-X IMAGING | 0,302 | +0,03 % | NANO-X IMAGING LTD: TCT 2026 Clinical Data Reveals 84% Reporting Gap in Aortic Valve Calcification, Highlighting the Potential of Nanox.AI's AVC Solution | ||
| TEMPEST THERAPEUTICS | 0,472 | +0,06 % | Tempest Therapeutics, Inc. - 8-K, Current Report | ||
| IMUNON | 0,790 | 0,00 % | Imunon, Inc. - S-1, General form for registration of securities |
ARDENT HEALTH INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,035 (-0,30 %) liegt der Kurs bei 11,715 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ARDENT HEALTH INC finden Sie auf Wallstreet Online.